Residency · Bethesda, MD
Sponsored by National Capital Consortium
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity.
The Journal of clinical endocrinology and metabolism · 2023 · 76 citations · Prem Subramanian
Exploring Diagnostic Precision and Triage Proficiency: A Comparative Study of GPT-4 and Bard in Addressing Common Ophthalmic Complaints.
Bioengineering (Basel, Switzerland) · 2024 · 35 citations · Ann Bidwell
The Risk of Sympathetic Ophthalmia Associated with Open-Globe Injury Management Strategies: A Meta-analysis.
Ophthalmology · 2024 · 13 citations · Grant Justin
Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy.
Brain : a journal of neurology · 2023 · 77 citations · Prem Subramanian
Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.
Cell reports. Medicine · 2024 · 45 citations · Prem Subramanian
Topographic analysis of local OCT biomarkers which predict progression to atrophy in age-related macular degeneration.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024 · 23 citations ·
Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease: A Meta-analysis and Matching-Adjusted Indirect Comparison.
JAMA ophthalmology · 2022 · 56 citations · Prem Subramanian
Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors.
Journal for immunotherapy of cancer · 2025 · 19 citations · Prem Subramanian